A new framework for analyzing mass transport in cortical brain tissue at <10 nm resolution

Elbert, D. L.; Esguerra, D. P.

doi:10.1101/2025.04.02.646802

Home/Archive/bioRxiv

bioRxiv · 10.1101/2025.04.02.646802

A new framework for analyzing mass transport in cortical brain tissue at <10 nm resolution

Elbert, D. L.·Esguerra, D. P.

View original source ↗Export metadata ↓

Abstract

Transmission electron microscopy of brain tissue yields high resolution maps of the spatial organization of cells in the central nervous system. Automated segmentation identifies distinct biological cells and the resulting segmented images are easily converted into surface meshes. The surface meshes are structural models of cell surfaces, providing a framework for modeling of mass transport within the interstitial fluid of brain tissue that surrounds the cells. Our goal is to model the production and clearance of proteins implicated in the development of Alzheimers Disease. This work introduces a new custom computational framework to allow massive parallelization of the solution of the mathematical equations of mass transfer. The diffusion equation was solved directly on the surface meshes of multiple biological cells in parallel, with exchange of mass across co-localized faces at the end of each time step. Mass transfer across the interfaces of multiple analysis volumes was incorporated using a semi-implicit approach. To demonstrate the capabilities of the framework, unsteady mass transfer along cell surfaces was modeled in an array of eight 4 x 4 x 4 m analysis volumes containing 2175 biological cells at 8 nm resolution, consisting of 313 million face elements. Areas of enhanced and hindered diffusive transport were identified, suggesting structural motifs that may contribute to the development of insoluble plaques. The tortuosity and fractional anisotropy were consistent with Diffusion Tensor Imaging (DTI) measurements in cortical tissue. This new framework allows modeling of diffusive mass transport while preserving anatomical details at <10 nm resolution. Author summaryA framework was developed to model mass transport around thousands of biological cells in parallel. This may be useful to identify structural features in cortical tissue that are more prone to the development of amyloid plaques.

Explore related subjects

bioengineering Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Elbert, D. L., Esguerra, D. P.. 2025-04-08. A new framework for analyzing mass transport in cortical brain tissue at <10 nm resolution. https://doi.org/10.1101/2025.04.02.646802

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Comparative study of chlorophyll measurement in Physcomitrium patens moss using a conventional microscope adapted for combined 2D+1D imaging and spectral analysis

Imaging spectroscopy often requires expensive and complex equipment. Here we show a simple procedure for attaching a standard miniature fiber spectrometer to a conventional microscope, allowing easy integration of 2D imaging with 1D high-resolution spectral measurements. This combination provides much of the benefit of a full imaging spectrometer without the large equipment investment, and we provide instructions for modifying microscopes to this setup and the present measurements of living cells that demonstrate their performance. Using this setup, we compare the quantitative measurement of chlorophyll concentration in Physcomitrium patens moss using color imaging and spectral sampling.

bioengineering↗

bioRxiv2026

De novo designed single-domain antibodies protect against lethal cobra venom neurotoxicity in vivo

Generative protein design can now rapidly produce de novo binders with high affinity and functional activity against a wide range of targets, including lethal snake venom toxins. However, so far most reported successes rely on new-to-nature scaffolds with limited therapeutic precedent. Single-domain antibodies (VHHs) offer a clinically validated alternative scaffold that can bind and neutralize long-chain -neurotoxins, which are some of the most lethal components in snake venoms. Here we compare three recently established de novo design models with VHH-design capabilities (Germinal, RFantibody, and BoltzGen) for their ability to generate VHHs against the neurotoxin -cobratoxin from the monocled cobra (Naja kaouthia). Using standardized model inputs and evaluation criteria based on AlphaFold3 interface confidence (ipTM) and RMSD self-consistency, we find that Germinal was the only method to generate designs passing stringent in silico criteria for experimental testing. We therefore performed a larger Germinal design campaign employing three different VHH frameworks and experimentally validated 46 designs in vitro. Of these, 42 expressed as soluble proteins and we identified four binding hits derived from two of the three tested frameworks. Of the four binders, two lead candidates were further characterized and demonstrated high affinity (KDs of 4.1 nM and 10.8 nM), monomeric behavior and low polyreactivity, indicating favorable biophysical and developability properties, as well as functional toxin neutralization in vitro. To assess their therapeutic potential we investigated their ability to protect against -cobratoxin toxicity in vivo. Both candidates fully protected mice after -cobratoxin challenge, with 100% survival compared to a lethal control. One candidate also retained notable neutralization capacity against whole venom of Naja kaouthia with a survival of 56%, while the other protected 22% when tested in a rescue setting. Together, we demonstrate that de novo VHH design can generate high affinity single-domain antibodies with in vivo protection against lethal cobra venom neurotoxicity, and provide practical insights into method- and framework-dependent performance.

bioengineering↗

bioRxiv2026

Simple Feedback for Complex Movement: Capturing Whole-Limb Reorganization during Single-IMU Gait Retraining

Clinical gait retraining typically relies on multi-sensor arrays and high-dimensional feedback displays, imposing setup and interpretation burdens that limit routine clinical deployment. We developed a single-IMU visual biofeedback system that delivers real-time feedback of Lower Limb Trajectory Error (LLTE), a composite kinematic error metric integrating knee position and shank angle across the stance phase. Twenty able-bodied adults walked on a treadmill under two visual biofeedback targets (flexed-knee, extended-knee) while receiving either corrected (n=10) or uncorrected (n=8) feedback, where the correction accounted for limb orientation at initial contact. LLTE and stance-phase knee kinematics adapted consistently under the flexed-knee target for both feedback groups, with feedback formulation moderating the temporal trajectory of change. Adaptation toward the extended-knee target was limited, likely because participants were already operating near terminal knee extension and because the scalar error metric provided limited directional information for correction. Ankle range of motion (ROM) changed significantly across the stance phase under both target conditions, while hip ROM did not. Multiscale multivariate sample entropy (MSMVSE) increased monotonically with time scale across all conditions, with no statistically distinguishable difference between corrected and uncorrected feedback. These results suggest that single-IMU LLTE biofeedback can modify gait mechanics and that adaptation was expressed across multiple lower-limb segments rather than through changes at a single joint.

bioengineering↗